Scientists develop new drug to fight gut 'superbugs'

Australia's Flinders University has announced that researchers have developed a new antibiotic that animal experiments have shown can be effective in suppressing a drug-resistant gut "superbug."
bacteria "resist" antibiotics in many forms to escape the risk of extinction, a resistance known as "bacterial resistance." Superbugs are bacteria that are resistant to a variety of antibiotics, and patients lack effective treatment after contracting superbugs. According to the World Health Organization, about 700,000 people die each year from drug-resistant infections such as superbugs.
"Difficult Thorespora" is a bacteria that can cause infection in the E. coli and has gradually developed resistance variants to traditional antibiotics, and is therefore a "superbug", which is common in people who have been taking antibiotics for a long time. The toxins secreted by the bacteria can wreak havoc on the intestines and threaten patients' lives. The Flinders University team reported in a new issue of the British journal Scientific Reports that they developed a new antibiotic called Ramizol, which was injected into hamsters infected with a lethal dose of Bacillus difficile, and found that a large proportion of the hamsters survived.
another study to assess drug safety, researchers injected 48 rats with high doses of Ramizol for 14 consecutive days. The results showed no serious side effects or weight changes in rats.
researchers say this suggests Ramizol is a well-resistant antibiotic for animals. In addition, Ramizol has good antioxidant properties and high chemical stability, and low manufacturing costs, is expected to be used in humans. (Source: Xinhua News Agency)